Tilray Brands is trading 6.6% up now at $4.75, with the move most consistent with broader risk appetite and consumer-staples strength.

  • The stock is rebounding from its August 18 close of $4.47.
  • No confirmed August 19 company-specific catalyst directly explains the move.
  • Tilray Medical’s August 18 Germany update was constructive but focused on policy clarity and unresolved legal questions; BrewDog’s announcement was a seasonal product launch.